Integra Lifesciences
(IART)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 246,375 | 276,402 | 456,661 | 513,448 | 470,166 |
| Marketable Securities | 27,192 | 32,694 | 0 | N/A | N/A |
| Receivables | 272,370 | 259,327 | 263,465 | 231,831 | 225,532 |
| Inventories | 429,090 | 389,608 | 324,583 | 317,386 | 310,117 |
| Other current assets | 29,653 | 32,643 | 31,032 | 0 | 162,105 |
| TOTAL | $1,081,681 | $1,058,036 | $1,161,498 | $1,153,716 | $1,237,202 |
| Non-Current Assets | |||||
| PPE Net | 405,723 | 340,199 | 311,302 | 311,703 | 287,529 |
| Intangibles | 2,304,540 | 2,123,295 | 2,165,490 | 2,159,031 | 1,921,803 |
| Other Non-Current Assets | 245,480 | 260,458 | 251,468 | 157,933 | 168,602 |
| TOTAL | $2,955,743 | $2,723,952 | $2,728,260 | $2,628,667 | $2,377,934 |
| Total Assets | $4,037,424 | $3,781,988 | $3,889,758 | $3,782,383 | $3,615,136 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 573,170 | 0 | N/A | N/A | 112,500 |
| Accounts payable and accrued liabilities | 82,502 | 92,326 | 102,100 | 61,837 | 54,608 |
| Accrued Expenses | 207,525 | 176,299 | 158,804 | 213,114 | 170,311 |
| Other current liabilities | 10,483 | 8,540 | 7,253 | 5,295 | 17,026 |
| TOTAL | $922,126 | $306,980 | $320,906 | $340,021 | $401,013 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,196,017 | 914,763 | 837,849 | 936,757 | 933,387 |
| Other Non-Current Liabilities | 313,168 | 937,044 | 863,262 | 775,013 | 749,679 |
| TOTAL | $1,570,018 | $1,887,124 | $1,764,449 | $1,757,558 | $1,699,256 |
| Total Liabilities | $2,492,144 | $2,194,104 | $2,085,355 | $2,097,579 | $2,100,269 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 77,219 | 78,220 | 81,636 | 83,243 | 84,370 |
| Common Shares | 916 | 909 | 905 | 896 | 893 |
| Retained earnings | 939,915 | 946,859 | 879,118 | 698,568 | 532,265 |
| Other shareholders' equity | -27,982 | -15,368 | 10,403 | -45,603 | -74,200 |
| TOTAL | $1,545,280 | $1,587,884 | $1,804,403 | $1,684,804 | $1,514,867 |
| Total Liabilities And Equity | $4,037,424 | $3,781,988 | $3,889,758 | $3,782,383 | $3,615,136 |